Cargando…
Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages
BACKGROUND: The difficulties of early diagnosis of colorectal cancer (CRC) result in a high mortality rate. The ability to predict the response of a patient to surgical resection or chemotherapy may be of great value for clinicians when planning CRC treatments. Metabolomics is an emerging tool for b...
Autores principales: | Li, Zhuofei, Deng, Xingming, Luo, Jun, Lei, Yunpeng, Jin, Xinghan, Zhu, Jing, Lv, Guoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855116/ https://www.ncbi.nlm.nih.gov/pubmed/35186705 http://dx.doi.org/10.3389/fonc.2021.574318 |
Ejemplares similares
-
Prognostic significance of periostin in colorectal cancer
por: Deng, Xingming, et al.
Publicado: (2019) -
Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy
por: Deng, Xingming, et al.
Publicado: (2018) -
Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer
por: Pei, Jun-Peng, et al.
Publicado: (2019) -
Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
por: Long, Zhiping, et al.
Publicado: (2020) -
Anticancer Properties of Curcumin Against Colorectal Cancer: A Review
por: Ojo, Oluwafemi Adeleke, et al.
Publicado: (2022)